BibbInstruments AB

BIBB · Nasdaq Stockholm · Healthcare

0.39SEK −3.0%last day

Price as of 1 October 2026

The price over the past year, with dividends: −89.8%

Performance

1 month

−22.3%

1 year

−89.8%

3 years, per year

−53.2%

5 years, per year

−44.4%

Largest fall, 3 years

−94.3%

Below the peak now

−97.4%

Volatility, 1 year

110.9%

Return with dividends reinvested.

Key figures

P/E

negative earnings

P/B

0.9

Dividend yield

0.0%

Return on equity

−28.3%

Net margin

–

Market value

6 m USD

Quality, value and trend

Where BibbInstruments stands against every Nordic stock today. 100 is best.

Quality44

Profitability and a sound balance sheet over time. Better than 44% of Nordic stocks.

Value20

The price measured against earnings, assets and cash flow. Better than 20% of Nordic stocks.

Trend11

The price development over the past year. Better than 11% of Nordic stocks.

Combined9

Quality, value and trend together. Better than 9% of Nordic stocks.

About BibbInstruments

BibbInstruments AB is a company in healthcare, listed on Nasdaq Stockholm. The share trades in SEK. It has around 4 employees.

BiBBInstruments AB, a medical technology company, develops and markets electrically powered endoscopic biopsy systems in the United States and Europe. The company offers EndoDrill which enables tissue sampling, with the aim of improving diagnostics in several common cancers, including those affecting the pancreas, stomach, liver, lungs, and urinary bladder. It also provides EndoDrill GI which used for endoscopic ultrasound; EndoDrill EBUS is used in the airways during endobronchial ultrasound (EBUS); and EndoDrill URO that is used with a standard cystoscope for sampling of muscle-invasive bladder cancer. The company was incorporated in 2013 and is headquartered in Lund, Sweden.

See the full analysis in InvestWiser.

The accounts, dividends, 40 years of charts and the comparison with other stocks are in the app.

See the full analysis